1. Home
  2. ARVN vs LWAY Comparison

ARVN vs LWAY Comparison

Compare ARVN & LWAY Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Arvinas Inc.

ARVN

Arvinas Inc.

HOLD

Current Price

$8.01

Market Cap

516.2M

Sector

Health Care

ML Signal

HOLD

LWAY

Lifeway Foods Inc.

HOLD

Current Price

$30.78

Market Cap

474.0M

ML Signal

HOLD

Company Overview

Basic Information
Metric
ARVN
LWAY
Founded
2015
1986
Country
United States
United States
Employees
N/A
N/A
Industry
Biotechnology: Pharmaceutical Preparations
Packaged Foods
Sector
Health Care
Consumer Staples
Exchange
Nasdaq
Nasdaq
Market Cap
516.2M
474.0M
IPO Year
2018
1995

Fundamental Metrics

Financial Performance
Metric
ARVN
LWAY
Price
$8.01
$30.78
Analyst Decision
Buy
Strong Buy
Analyst Count
19
2
Target Price
$15.05
$34.50
AVG Volume (30 Days)
647.9K
181.0K
Earning Date
05-04-2026
05-14-2026
Dividend Yield
N/A
N/A
EPS Growth
58.84
48.33
EPS
N/A
0.30
Revenue
$262,600,000.00
$103,350,000.00
Revenue This Year
N/A
$16.64
Revenue Next Year
N/A
$17.28
P/E Ratio
N/A
$101.10
Revenue Growth
N/A
N/A
52 Week Low
$6.06
$17.31
52 Week High
$14.22
$34.20

Technical Indicators

Market Signals
Indicator
ARVN
LWAY
Relative Strength Index (RSI) 42.94 57.65
Support Level $7.90 $22.03
Resistance Level $8.90 $31.23
Average True Range (ATR) 0.31 1.35
MACD -0.01 -0.29
Stochastic Oscillator 6.00 58.21

Price Performance

Historical Comparison
ARVN
LWAY

About ARVN Arvinas Inc.

Arvinas Inc is a clinical-stage biotechnology company focused on improving the lives of patients suffering from debilitating and life-threatening diseases through the discovery, development, and commercialization of therapies that degrade disease-causing proteins. The company is using its PROteolysis TArgeting Chimera, a protein degradation platform, to develop therapeutics designed to harness the body's own natural protein disposal system to selectively and efficiently degrade and remove disease-causing proteins. Its clinical development program includes various product candidates such as ARV-102, ARV-806, ARV-393, ARV-027, and vepdegestrant, in their different stages of development, being developed to target certain harmful proteins causing oncology and neurology-related diseases.

About LWAY Lifeway Foods Inc.

Lifeway Foods Inc is engaged in manufacturing probiotic, cultured, functional dairy health food products. Its primary product is drinkable kefir, which is a cultured dairy product. Its product categories are Drinkable Kefir, which is the key revenue-driving product, European-style soft cheeses, Cream, ProBugs, Frozen Kefir, and Other dairy. The company manufactures and markets products under the Lifeway and Fresh Made brand names, as well as under private labels on behalf of customers. It sells the products through a direct sales force, brokers, and distributors.

Share on Social Networks: